Revenue performance: 4,149,000,000 USD in QQ4 2024; YoY growth +11.53%; QoQ growth 0.00%. Gross profit: 1,612,000,000 USD; gross margin 38.85%; YoY gross profit change +1.83%; QoQ change 0.00%. Operating income: 259,000,000 USD; operating margin 6.24%; YoY operating income change -11.60%; QoQ change 0.00%. Net income: 206,000,000 USD; net margin 4.97%; YoY net income change 0.00%; QoQ change 0.00%. Earnings per share (EPS): Basic 0.53 USD; Diluted 0.54 USD; YoY EPS change -3.64%; QoQ change 0.00%. EBITDA: 408,000,000 USD; EBITDARatio 0.0983.
Cash flow and liquidity: Net cash provided by operating activities 616,000,000 USD; free cash flow 499,000,000 USD; cash at end of period 2.327B USD; cash at beginning 1.969B USD; capital expenditures 117,000,000 USD; dividends paid 56,000,000 USD; common stock repurchased 75,000,000 USD; total debt 5.475B USD; net debt 3.14B USD.
Balance sheet health: Total assets 11.885B USD; total liabilities 8.621B USD; total stockholders’ equity 3.264B USD; current assets 5.203B USD; inventory 2.067B USD; current liabilities 3.256B USD; cash and cash equivalents 2.335B USD; short-term investments 0.253B USD; long-term debt 4.843B USD.